Winston Taylor is noted for its work on UPC matters and infringement disputes for clients in the pharma and medical device sectors, with regulatory advice forming a further core part of its practice. Practice co-head Wim Maas regularly covers patent litigation matters, while fellow co-head Bas Berghuis van Woortman, who joined the team from Simmons & Simmons, specialises in the full breadth of intellectual property law, with an emphasis on patent and technology-focused litigation. Charlotte Garnitsch and Eelco Bergsma left the firm.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
- 'Bas Berghuis van Woortman and Sebastian Versaevel are great patent litigators with an eye for detail, but not leaving the greater strategy out of sight.'
- 'Wim Maas is outstanding, especially in UPC cases.'
Key clients
- Pfizer
- Abbott
- Tandem Diabetes Care
- Glenmark
- Fresenius
- Accord
- Rubin Medical
- Netherlands Cancer Institute
- Med-El
- Samsung Bioepis
- LinXis
- Cathay
Work highlights
Representing Pfizer in its dispute regarding the Covid-19 vaccine of Pfizer and BioNTech.
Representing Abbott in multi-jurisdictional patent litigation against Dexcom.
Represented Tandem Diabetes Care in three UPC actions against F. Hoffman-La Roche AG and Roche Diabetes Care.
Lawyers
Leading partners
The strongest partners in their field, leading on market-leading deals and endorsed by peers and clients alike.
Practice head
Wim Maas; Bas Berghuis van Woortman
Other key lawyers
Margot van Gerwen; Sebastian Versaevel